KEROS THERAPEUTICS INC (KROS) Stock Analyst Earnings Estimates
NASDAQ:KROS - Nasdaq - US4923271013 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20.1M | -100.00% | 151K | 608.94K 303.27% | 61.2K -89.95% | 5.37M 8,674.51% | 61.978M 1,054.15% | 72.005M 16.18% | 135.57M 88.28% | 190.95M 40.85% | 345.49M 80.93% | 468.23M 35.53% | |
| EBITDA YoY % growth | -55.99M -20.72% | -114.12M -103.82% | -169.126M -48.20% | -190.613M -12.70% | -213.746M -12.14% | -198.39M 7.18% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -56.37M -20.81% | -114.79M -103.64% | -169.941M -48.05% | -200.955M -18.25% | -216.871M -7.92% | -201.994M 6.86% | -236.921M -17.29% | -208.854M 11.85% | -193.802M 7.21% | -178.002M 8.15% | -83.435M 53.13% | -32.053M 61.58% | |
| Operating Margin | -280.45% | N/A | -112,543.71% | -33,000.84% | -354,365.17% | -3,761.53% | -382.27% | -290.06% | -142.95% | -93.22% | -24.15% | -6.85% | |
| EPS YoY % growth | -2.52 63.05% | -4.15 -64.68% | -5.20 -25.30% | -5.29 -1.80% | -4.94 6.71% | -4.45 9.93% | -4.59 -3.19% | -3.56 22.44% | -2.76 22.52% | -2.35 14.64% | 0.64 127.08% | 1.41 120.40% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.00 25.17% | -0.76 37.43% | -1.24 1.17% | -1.15 18.26% | -1.25 -24.35% | -0.79 -3.74% | -0.80 35.60% | -0.80 30.97% | -0.80 36.20% |
| Revenue Q2Q % growth | 15.732M 10,901.40% | 14.576K -82.44% | 14.576K -60.61% | 2.578M 564.43% | 12.75K -99.92% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -49.409M -8.26% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.412M 40.99% | -24.53M 49.41% | -53.259M -5.59% | -52.468M 10.55% | -54.371M -98.34% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.41 -6.02% | -1.30 | -0.11 | -8.05% |
| Q2 2024 Q2Q % growth | -1.25 1.57% | -1.26 | 0.01 | 0.53% |
| Q1 2024 Q2Q % growth | -1.21 3.97% | -1.37 | 0.16 | 11.93% |
| Q4 2023 Q2Q % growth | -1.34 -22.94% | -1.40 | 0.06 | 4.43% |
| Q3 2023 Q2Q % growth | -1.33 -44.57% | -1.37 | 0.04 | 3.25% |
| Q2 2023 Q2Q % growth | -1.27 -12.39% | -1.37 | 0.10 | 6.98% |
| Q1 2023 Q2Q % growth | -1.26 -24.75% | -1.15 | -0.11 | -10.01% |
| Q4 2022 Q2Q % growth | -1.09 -263.33% | -1.12 | 0.03 | 2.60% |
| Q3 2022 Q2Q % growth | -0.92 -5.75% | -1.26 | 0.34 | 26.77% |
| Q2 2022 Q2Q % growth | -1.13 -68.66% | -1.08 | -0.05 | -4.71% |
| Q1 2022 Q2Q % growth | -1.01 -48.53% | -0.88 | -0.13 | -14.81% |
| Q4 2021 Q2Q % growth | -0.30 38.78% | -0.94 | 0.64 | 67.94% |
| Q3 2021 Q2Q % growth | -0.87 -45.00% | -0.74 | -0.13 | -18.05% |
| Q2 2021 Q2Q % growth | -0.67 -8.06% | -0.67 | 0.00 | -0.28% |
| Q1 2021 Q2Q % growth | -0.68 86.69% | -0.59 | -0.09 | -14.94% |
| Q4 2020 Q2Q % growth | -0.49 | -0.58 | 0.09 | 15.72% |
| Q3 2020 Q2Q % growth | -0.60 | -0.61 | 0.01 | 1.14% |
| Q2 2020 Q2Q % growth | -0.62 | -0.69 | 0.07 | 9.95% |
| Q1 2020 Q2Q % growth | -5.11 | -0.38 | -4.73 | -1,254.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 165.75K | -165.75K | -100.00% | |
| Q1 2023 Q2Q % growth | 221.003K | -221.003K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 874.283K | -874.283K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | 6.12M | -6.12M | -100.00% | |
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | 63.75K | -63.75K | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | 63.75K | -63.75K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 84.997K | -84.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 31.08% | 26.85% | 0.28% | -0.44% |
| Revenue | 33320.4% | 568.31% | -0.03% | -69.73% |